CPRX
Price
$24.44
Change
+$0.53 (+2.22%)
Updated
Feb 6 closing price
Capitalization
3B
37 days until earnings call
Intraday BUY SELL Signals
GPCR
Price
$74.92
Change
+$1.71 (+2.34%)
Updated
Feb 6 closing price
Capitalization
5.29B
45 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CPRX vs GPCR

Header iconCPRX vs GPCR Comparison
Open Charts CPRX vs GPCRBanner chart's image
Catalyst Pharmaceuticals
Price$24.44
Change+$0.53 (+2.22%)
Volume$1.03M
Capitalization3B
Structure Therapeutics
Price$74.92
Change+$1.71 (+2.34%)
Volume$1.1M
Capitalization5.29B
CPRX vs GPCR Comparison Chart in %
CPRX
Daily Signal:
Gain/Loss:
GPCR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CPRX vs. GPCR commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPRX is a Buy and GPCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (CPRX: $24.44 vs. GPCR: $74.92)
Brand notoriety: CPRX and GPCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CPRX: 82% vs. GPCR: 63%
Market capitalization -- CPRX: $3B vs. GPCR: $5.29B
CPRX [@Biotechnology] is valued at $3B. GPCR’s [@Biotechnology] market capitalization is $5.29B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPRX’s FA Score shows that 1 FA rating(s) are green whileGPCR’s FA Score has 0 green FA rating(s).

  • CPRX’s FA Score: 1 green, 4 red.
  • GPCR’s FA Score: 0 green, 5 red.
According to our system of comparison, CPRX is a better buy in the long-term than GPCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPRX’s TA Score shows that 5 TA indicator(s) are bullish while GPCR’s TA Score has 4 bullish TA indicator(s).

  • CPRX’s TA Score: 5 bullish, 4 bearish.
  • GPCR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CPRX is a better buy in the short-term than GPCR.

Price Growth

CPRX (@Biotechnology) experienced а +0.58% price change this week, while GPCR (@Biotechnology) price change was -15.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

CPRX is expected to report earnings on Mar 18, 2026.

GPCR is expected to report earnings on Mar 26, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GPCR($5.29B) has a higher market cap than CPRX($3B). GPCR YTD gains are higher at: 7.721 vs. CPRX (4.713). CPRX has higher annual earnings (EBITDA): 297M vs. GPCR (-246.42M). GPCR has more cash in the bank: 799M vs. CPRX (690M). CPRX has less debt than GPCR: CPRX (2.89M) vs GPCR (7.09M). CPRX has higher revenues than GPCR: CPRX (578M) vs GPCR (0).
CPRXGPCRCPRX / GPCR
Capitalization3B5.29B57%
EBITDA297M-246.42M-121%
Gain YTD4.7137.72161%
P/E Ratio14.29N/A-
Revenue578M0-
Total Cash690M799M86%
Total Debt2.89M7.09M41%
FUNDAMENTALS RATINGS
CPRX: Fundamental Ratings
CPRX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
21
SMR RATING
1..100
34
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
81
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CPRXGPCR
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
76%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 8 days ago
87%
Declines
ODDS (%)
Bearish Trend 5 days ago
68%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
71%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CPRX
Daily Signal:
Gain/Loss:
GPCR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WBSRX36.041.09
+3.12%
William Blair Small Cap Growth R6
PMJIX12.470.30
+2.47%
PIMCO RAE US Small Instl
JVMRX29.830.63
+2.16%
JHancock Disciplined Value Mid Cap R6
AWYIX64.141.15
+1.83%
CIBC Atlas Equity Income Institutional
BGVIX36.500.58
+1.61%
Brandes Global Equity I

CPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CPRX has been loosely correlated with OLMA. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CPRX jumps, then OLMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPRX
1D Price
Change %
CPRX100%
+2.22%
OLMA - CPRX
57%
Loosely correlated
+1.40%
NRIX - CPRX
56%
Loosely correlated
+5.64%
IPSC - CPRX
55%
Loosely correlated
+1.80%
GPCR - CPRX
55%
Loosely correlated
+2.34%
CGEM - CPRX
54%
Loosely correlated
+3.21%
More

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been closely correlated with TERN. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if GPCR jumps, then TERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
+2.34%
TERN - GPCR
84%
Closely correlated
+6.88%
PRAX - GPCR
80%
Closely correlated
+4.56%
ACET - GPCR
80%
Closely correlated
+9.16%
STRO - GPCR
79%
Closely correlated
+6.30%
ATOS - GPCR
79%
Closely correlated
+0.19%
More